Skip to main content

Recombinant Human IFN-alpha-1b Protein, CF

Bio-Techne includes R&D Systems | Catalog # 11015-IF

Catalog #
Availability
Size / Price
Qty
Loading...
11015-IF-010
11015-IF-050

Key Product Details

Source

HEK293

Accession #

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human IFN-alpha 1 protein
Cys24-Glu189

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

N-terminal Sequence Analysis

Cys24

Predicted Molecular Mass

19 kDa

SDS-PAGE

17-21 kDa, under reducing conditions.

Activity

Measured in anti-viral assays using HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129.
The ED50 for this effect is 30.0-300 pg/mL.

Scientific Data Images for Recombinant Human IFN-alpha-1b Protein, CF

Recombinant Human IFN-alpha-1b Protein Bioactivity.

Recombinant Human IFN-alpha-1b Protein (Catalog # 11015-IF) demonstrates anti-viral activity in HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. The ED50 for this effect is 30.0‑300 pg/mL.

Recombinant Human IFN-alpha-1b Protein SDS-PAGE.

2 μg/lane of Recombinant Human IFN-alpha-1b Protein (Catalog # 11015-IF) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 17-21 kDa.

Formulation, Preparation and Storage

11015-IF
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: IFN-alpha 1

Interferons (IFN) are a family of cytokines with potent antiviral, antiproliferative and immunomodulatory properties, classified based on their binding specificity to cell surface receptors (1). Human IFNA2 was originally cloned in the early ‘80s and now more than a dozen closely related IFN alpha subtypes have been identified in both the human and mouse genome, each sharing about 80% amino acid (aa) sequence homology (2-4). Structurally, type I IFNs belong to the class of five helical‑bundle cytokines, with the IFNA subtypes containing 2 conserved disulfide bonds (5). The extracellular domain (ECD) of mature human IFNA1, also known as IFNA13, shares 63% aa sequence identity with mouse IFNA1. Two variants of human IFNA1 are known to exist, IFNA1a and IFNA1b, which only differ by a single residue at position 137 (6). The type I IFNs bind to the interferon alpha receptor (IFNAR), which consists of two subunits: IFNAR1 (alpha ‑subunit) and IFNAR2 (beta ‑subunit) (7, 8). IFNA1 is the most expressed IFNA subtype and primarily expressed by plasmacytoid dendritic cells (pDC), which are the earliest cells recruited to the sites of virus entry (9). Individual IFNA subtypes are known to display unique efficacies to viral protection, and IFNA1 exhibits low potency, determined by both antiviral and antiproliferative activities (10). Human IFNA1 was the first IFNA to be purified and has been tested as a treatment for various diseases (11-13).

References

  1. Pestka S, et al. (1987) Annu Rev Biochem. 56:727.
  2. Goeddel, D.V. et al. (1980) Nature 287:411.
  3. Matsumiya, T. et al. (2007) J. Immunol. 179:4542.
  4. Schreiber, G. and J. Piehler (2015) Trends Immunol. 36:139.
  5. Wittling, M.C. et al. (2021) Front Immunol. 11:605673.
  6. Hussain, M. et al. (2000) J Interferon Cytokine Res. 20:763.
  7. van Pesch, V. et al. (2004) J. Virol. 78:8219.
  8. James, C.M. et al. (2007) Vaccine. 25(10):1856.
  9. Szubin, R. et al. (2008). J Interferon Cytokine Res. 28:749.
  10. Moll, H.P. et al. (2011) Cytokine. 53:52.
  11. Rubinstein, M. et al. (1978) Science. 202:1289.
  12. Harper, M.S. et al. (2015) PLOS Pathogens 11:e1005254.
  13. George, J. and Mattapallil, J.J. (2018) Front Immunol. 9:299.

Long Name

Interferon alpha 1

Alternate Names

IFNA1, IFNalpha 1

Entrez Gene IDs

3439 (Human); 15962 (Mouse); 690894 (Rat)

Gene Symbol

IFNA1

UniProt

Additional IFN-alpha 1 Products

Product Documents for Recombinant Human IFN-alpha-1b Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human IFN-alpha-1b Protein, CF

For research use only

Loading...
Loading...